News

Under the terms of the agreement, Breg will continue to supply Novation with its comprehensive lines of functional, osteoarthritis, patellofemoral and postoperative knee braces. Additionally, under this new

Genentech has reported that a Phase III study of Avastin plus chemotherapy following surgery in patients with early-stage colon cancer did not meet its primary endpoint of reducing

Transave has completed patient enrollment in a Phase II study evaluating the safety and efficacy of Arikace in non-cystic fibrosis bronchiectasis patients. The double-blind, placebo-controlled study is designed

In this role, Mr Nicklas will oversee sales, marketing and managed care efforts for BTA’s products. Prior to joining Biovail, Mr Nicklas was senior director of epilepsy marketing

Neoteric’s products will be integrated into Haemonetics’s patient division for marketing and sales. The company’s operations will remain in Vancouver, British Columbia and the UK. Natixis Bleichroeder acted

The data show that RGB-286638 demonstrates in vivo activity in several preclinical models of multiple myeloma. The compound also induces cell death in multiple myeloma cells independent from

Patient Safety Technologies, a developer, manufacturer and provider of patient safety products and services, has reported a net loss of $630,000, or $0.05 per share, for the fourth

Quarterly Snapshot Revenues decreased 12% Adjusted EPS declined 15% Generated record free cash flow of more than $310 million Significant new products launched to address customer needs for

Business Outlook For the fiscal 2009, the company anticipates total revenue to be in the range of $164 million to $174 million, loss per share in the range